The clinical efficacy of first-generation carcinoembryonic...

  • Main
  • 2017 / 6
  • The clinical efficacy of first-generation carcinoembryonic...
Cancer Immunology, Immunotherapy 2017 / 6

The clinical efficacy of first-generation carcinoembryonic antigen (CEACAM5)-specific CAR T cells is limited by poor persistence and transient pre-conditioning-dependent respiratory toxicity

Thistlethwaite, Fiona C., Gilham, David E., Guest, Ryan D., Rothwell, Dominic G., Pillai, Manon, Burt, Deborah J., Byatte, Andrea J., Kirillova, Natalia, Valle, Juan W., Sharma, Surinder K., Chester,
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Language:
english
Journal:
Cancer Immunology, Immunotherapy
DOI:
10.1007/s00262-017-2034-7
Date:
June, 2017
File:
PDF, 717 KB
english, 2017
Conversion to is in progress
Conversion to is failed